TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.
Xu, Qianqian
TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. [electronic resource] - Oncotarget Dec 2016 - 81815-81829 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.13245 doi
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--analysis
Cell Cycle Proteins--analysis
Chi-Square Distribution
Disease-Free Survival
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Middle Aged
Multivariate Analysis
Predictive Value of Tests
Proportional Hazards Models
Protein Serine-Threonine Kinases--analysis
Protein-Tyrosine Kinases--analysis
ROC Curve
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
Triple Negative Breast Neoplasms--enzymology
Up-Regulation
Young Adult
TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. [electronic resource] - Oncotarget Dec 2016 - 81815-81829 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.13245 doi
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--analysis
Cell Cycle Proteins--analysis
Chi-Square Distribution
Disease-Free Survival
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Middle Aged
Multivariate Analysis
Predictive Value of Tests
Proportional Hazards Models
Protein Serine-Threonine Kinases--analysis
Protein-Tyrosine Kinases--analysis
ROC Curve
Retrospective Studies
Risk Factors
Time Factors
Treatment Outcome
Triple Negative Breast Neoplasms--enzymology
Up-Regulation
Young Adult